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Abstract
Background:  The rational design of L-phenylalanine (L-Phe) overproducing microorganisms has been
successfully achieved by combining different genetic strategies such as inactivation of the phosphoenolpyruvate:
phosphotransferase transport system (PTS) and overexpression of key genes (DAHP synthase, transketolase and
chorismate mutase-prephenate dehydratase), reaching yields of 0.33 (g-Phe/g-Glc), which correspond to 60% of
theoretical maximum. Although genetic modifications introduced into the cell for the generation of
overproducing organisms are specifically targeted to a particular pathway, these can trigger unexpected
transcriptional responses of several genes. In the current work, metabolic transcription analysis (MTA) of both
L-Phe overproducing and non-engineered strains using Real-Time PCR was performed, allowing the detection of
transcriptional responses to PTS deletion and plasmid presence of genes related to central carbon metabolism.
This MTA included 86 genes encoding enzymes of glycolysis, gluconeogenesis, pentoses phosphate, tricarboxylic
acid cycle, fermentative and aromatic amino acid pathways. In addition, 30 genes encoding regulatory proteins and
transporters for aromatic compounds and carbohydrates were also analyzed.
Results: MTA revealed that a set of genes encoding carbohydrate transporters (galP, mglB), gluconeogenic (ppsA,
pckA) and fermentative enzymes (ldhA) were significantly induced, while some others were down-regulated such
as ppc, pflB, pta and ackA, as a consequence of PTS inactivation. One of the most relevant findings was the
coordinated up-regulation of several genes that are exclusively gluconeogenic (fbp, ppsA, pckA, maeB, sfcA, and
glyoxylate shunt) in the best PTS- L-Phe overproducing strain (PB12-ev2). Furthermore, it was noticeable that
most of the TCA genes showed a strong up-regulation in the presence of multicopy plasmids by an unknown
mechanism. A group of genes exhibited transcriptional responses to both PTS inactivation and the presence of
plasmids. For instance, acs-ackA, sucABCD, and sdhABCD operons were up-regulated in PB12 (PTS mutant that
carries an arcB- mutation). The induction of these operons was further increased by the presence of plasmids in
PB12-ev2. Some genes involved in the shikimate and specific aromatic amino acid pathways showed down-
regulation in the L-Phe overproducing strains, might cause possible metabolic limitations in the shikimate pathway.
Conclusion: The identification of potential rate-limiting steps and the detection of transcriptional responses in
overproducing microorganisms may suggest "reverse engineering" strategies for the further improvement of L-
Phe production strains.
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Background
Metabolic engineering is the specific modification of the
metabolic pathways or the introduction of new ones
within the host organism by means of genetic engineering
techniques [1]. In the context of L-phenylalanine (L-Phe)
production, the challenge to design and construct L-Phe
overproducing strains has been approached by using sev-
eral genetic strategies: 1) the deregulation and overexpres-
sion of key enzymes. For example 3-deoxy-D-arabino-
heptulosonate 7-phosphate (DAHP) synthase and choris-
mate-mutase prefenate-dehydratase (CM-PDT), are two
essential steps to overcome these metabolic bottlenecks
that strongly control the carbon flux directed into the bio-
synthesis of L-Phe. 2) When these rate-limiting steps have
been overcome, additional strategies are necessary to
increase the availability of precursors for aromatic biosyn-
thesis: phosphoenolpyruvate (PEP) and erythrose 4-phos-
phate (E4P). Some of these genetic strategies have been
successfully applied, achieving the purpose of increasing
PEP and E4P availability [2-5]. In general, these consist of
inactivating enzymes that consume PEP and/or overex-
pressing enzymes that produce E4P and/or PEP. For
instance, the overexpression of either transketolase (tktA)
or transaldolase (talA) combined with the overexpression
of feedback insensitive DAHP synthase increased the syn-
thesis of aromatic compounds in E. coli strains, presuma-
bly by increasing E4P availability [2,6,7]. Alternatively,
the overexpression of PEP synthase (ppsA) in E. coli aug-
mented PEP availability, and thereby, the yield in the syn-
thesis of aromatic compounds from glucose [8]. Likewise,
the inactivation of PEP carboxylase (ppc) or pyruvate
kinases (pykA, pykF) also led to an increase in PEP availa-
bility [9-11]. The inactivation of the main glucose trans-
port system, known as phosphoenolpyruvate:
carbohydrate phosphotransferase system (PTS) has
shown a great impact on PEP availability, increasing sub-
stantially the biosynthetic capacity of aromatic com-
pounds [2,11-16]. The construction of PTS mutants (PTS-
Glc-) has been reported and from these strains spontane-
ous PTS-Glc+  mutants were selected, which have an
enhanced capacity to transport glucose [2]. Briefly, dele-
tion of the PTS operon (ptsHIcrr) in strain JM101 (µ = 0.71
h-1) generated strain PB11 (PTS-), which grows slowly in
minimal media supplemented with glucose (µ = 0.1 h-1).
The PB11 mutant was subjected to an adaptive evolution
process in which spontaneous PB12 (µ = 0.42 h-1) and
PB13 (µ = 0.49 h-1) mutants were isolated, showing a sig-
nificantly higher specific growth rate on glucose (PTS-Glc+
phenotype) than in PB11 [2]. Further characterization of
PB12 and PB13 mutants showed that glucose is mainly
internalized into the cell by the galactose permease (GalP)
and phosphorylated by glucokinase (Glk) [17,18] (Fig-
ures 1, 2). At least two spontaneous mutations occurred
when PB12 was selected, being one of them a mutation in
arcB gene that is partially responsible for the up-regula-
tion of TCA cycle genes when this strain grows on glucose
as the sole carbon source [18,19]. In addition, metabolic
flux analysis, using NMR, revealed that these mutants
exhibit important changes in the distribution of carbon
flux at the level of the central metabolism [17]. The redis-
tribution of carbon fluxes in PTS mutants can be benefi-
cial for the synthesis of aromatic compounds, as has been
suggested by studies of the NF9 strain (PTS-Glc+) engi-
neered to overproduce the first aromatic intermediate
(DAHP) [2,12]. In the latter works, it was shown that PTS
inactivation has a positive impact on the productivity and
yield of DAHP from glucose. The advantage of PTS
mutants for the production of aromatic compounds has
been confirmed with the successful construction of L-Phe
overproducing E. coli strains, combining the simultaneous
overexpression of transketolase (tktA), feedback insensi-
tive DAHP synthase (aroGfbr) and evolved feedback insen-
sitive chorismate-mutase prefenate-dehydratase CM-
PDTev2 (pheAev2) in a PTS-Glc+ genetic background [15].
Thus, a PTS-Glc+  derivative carrying appropriate plas-
mids(PB12-ev2) showed a substantial improvement in L-
Phe yield from glucose (YPhe/Glc = 0.33 g/g) with regards to
PTS+ strain (JM101-ev2, YPhe/Glc = 0.22 g/g). These yields
correspond to 60 and 40% of the theoretical maximum,
respectively.
Recombinant DNA technology allows the introduction of
specific genetic modifications within particular metabolic
pathways. However, these manipulations can trigger
directly or indirectly transcriptional responses of several
genes, as a consequence of the inextricable complexity
and connectivity of the metabolic and regulatory net-
works. Accordingly, some transcriptional responses in the
cell may be associated with a high degree of unpredictabil-
ity, and thereby with unexpected effects sometimes oppo-
site to those desired. For instance, the use of multicopy
plasmids is a very common procedure in metabolic engi-
neering to construct recombinant organisms. However,
plasmid metabolic burden is an important factor that
should be taken into account when genetically engineer-
ing a strain, because broad effects on several cellular proc-
esses have been reported. Metabolic burden imposes an
extra demand on cellular processes, which in turn, gener-
ate a high demand on the syntheses of precursor mole-
cules, causing a reduction in the specific growth rate [20].
Saturation effects could also occur on cellular machineries
and/or competition effects of the overexpressed gene(s)
with the host cell genes and proteins. This in turn could
also decrease the transcription and translation rate of
other genes and mRNAs, and accordingly, the enzyme
pools (dilution effect) [21-23]. Furthermore, it has been
reported that overexpression of recombinant proteins in
E. coli triggers induction of stress responses such as heat
shock and SOS/DNA damage [24]. However, despite the
importance of carbon central metabolism, as far as weMicrobial Cell Factories 2007, 6:30 http://www.microbialcellfactories.com/content/6/1/30
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Glucose transport and central metabolism reactions in E. coli strains with an active PTS Figure 1
Glucose transport and central metabolism reactions in E. coli strains with an active PTS. Glucose transport 
through outer and inner membranes and main pathways involved in the biosynthesis of L-Phe in strains with an active PTS 
(strain JM101).
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Glucose transport and central metabolism reactions in E. coli strains with an inactive PTS Figure 2
Glucose transport and central metabolism reactions in E. coli strains with an inactive PTS. Glucose transport 
through outer and inner membranes in derivative E. coli strains with an inactive PTS. These strains such as PB12-ev2 and PB13-
ev2 use GalP and Glk for glucose transport and phosphorylation.
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know, there are no reports about the effects of plasmid
presence on the transcription of genes involved in this
part of the cellular physiology.
Basic and applied studies of Metabolic Transcription Anal-
ysis (MTA) may be valuable, because have the potential
to: 1) determine transcriptional responses to the genetic
modifications introduced into the organism during the
process of genetic engineering, providing a deep insight
on the physiological mechanisms of the cell; 2) identify
significant transcript changes of key genes related to the
biosynthesis of a desired metabolite in organisms that
overproduce it; 3) identify transcriptional responses to
multi-copy plasmid presence in the strain engineering
process; 4) associate significant transcriptional alterations
with the metabolic capacity of the cell, which can be
assessed in terms of yields and productivities of the
desired metabolite; 5) detect potential rate limiting steps
in the transcription of key genes, which may be the basis
to formulate new hypothesis and genetic strategies
("reverse engineering") to further improve the microbial
cell factories.
Microarray and Real Time-PCR (RT-PCR) technologies are
used to generate information about transcriptional
responses to different conditions. Transcriptional analysis
by RT-PCR has several advantages, for example, the sensi-
tivity and accuracy of measurements is very high because
the mRNA signal is exponentially amplified. This is espe-
cially useful when detecting mRNAs that are weakly
expressed. Furthermore, statistical analysis of RT-PCR data
has been shown to be relatively straightforward. On the
other hand, microarray technology enables genome-wide
transcriptional analyses, whereas RT-PCR-based methods
have a practical limit of about a couple hundred genes.
Therefore, RT-PCR analyses might leave out genes
responding to a specific experimental condition.
Transcriptional characterization of metabolic genes in
PB11 and PB12 mutants grown on glucose as the only car-
bon source has been reported using RT-PCR [18,19,25]. In
the current study, MTA of 116 genes involved in glycolysis
(Embden-Meyerhof-Parnas), gluconeogenesis, tricarboxy-
lic acid cycle (TCA), pentose phosphate (PP), aromatic
amino acids, anaplerotic and fermentative pathways was
performed. In addition, the transcription of genes encod-
ing regulatory proteins and transporters for aromatic com-
pounds and carbohydrates were also analyzed. These
genes are involved in the metabolic and regulatory net-
works related to aromatics biosynthesis in E. coli. RT-PCR
technology was chosen in this study to provide precise
transcriptional data for genes from these specific segments
of the cell's physiology. This work describes, for the first
time, metabolic transcriptional responses to PTS inactiva-
tion and multi-copy plasmid presence in PTS+ and PTS- L-
Phe overproducing E. coli strains when they are grown on
glucose and yeast extract as carbon sources. These studies
permitted the identification of potential rate-limiting
steps in the biosynthesis of L-Phe. This knowledge may
provide strong basis for the design of new hypothesis and
genetic strategies, which may further improve YPhe/Glc and
productivity of L-Phe in E. coli strains.
Results and Discussion
The generation of L-Phe overproducing E. coli strains com-
bining genetic strategies, such as PTS inactivation and the
overexpression of key genes in the L-Phe synthesis
(aroGfbr, tktA and pheAev2) has been reported [15]. Glucose
transport through outer and inner membranes in PTS+
and PTS-Glc+ genetic backgrounds is shown in Figures 1, 2,
respectively, as well as the main pathways involved in the
biosynthesis of L-Phe and genetic strategies used for the
construction of L-Phe overproducing strains. Even though
strains PB12-ev2 and PB13-ev2 have the same PTS-Glc+
phenotype, they accumulated different acetate and L-Phe
amounts in resting cell cultures using glucose as the sole
carbon source (table 1). In addition, they exhibited signif-
icant differences in terms of L-Phe yield and specific pro-
ductivity. The current MTA included host strains (JM101,
PB12 and PB13) and their derivatives L-Phe overproduc-
ing strains (JM101-ev2, PB12-ev2 and PB13-ev2) grown
in M9 medium supplemented with glucose (10 g/L) and
yeast extract (5 g/L). In additional file 1, all RT-PCR data
are reported as relative gene transcription levels and have
been referred to JM101 strain (reference strain). The refer-
ence to JM101 strain will be always assumed and hence
Table 1: Accumulation of aromatic intermediates, acetate, L-Phe yields and productivities in L-Phe overproducing strains assessed in 
resting cell cultures containing 1 g of biomass. The results of the JM101-ev2, PB12-ev2 and PB13-ev2 strains have been previously 
reported [15, 69].
Strains qGlc (g/
gDCW·h)
qAcetate (mg/
gDCW·h)
DHS (g/L) SHIK (g/L) L-Phe (g/L) YPhe/Glc qPhe (mg/
gDCW·h)
JM101-ev2 0.17 ± 0.01 70 ± 0.41 0.020 ± 0.001 0.029 ± 0.002 0.396 ± 0.025 0.22 ± 0.01 36.34 ± 2.50
PB12-ev2 0.12 ± 0.01 30 ± 0.22 0.054 ± 0.003 0.034 ± 0.001 0.460 ± 0.015 0.33 ± 0.01 40.60 ± 3.17
PB13-ev2 0.14 ± 0.01 40 ± 0.25 0.054 ± 0.004 0.034 ± 0.002 0.300 ± 0.019 0.20 ± 0.02 29.25 ± 2.50
Symbols: qGlc, specific consumption rate of glucose; qAcetate, specific consumption rate of acetate; qPhe, specific production rate of phenylalanine; YPhe/
Glc, yield of phenylalanine synthesized from glucose. DHS, 5-dehydroshikimate; SHIK, shikimate; gDCW, grams of dry cell weight.Microbial Cell Factories 2007, 6:30 http://www.microbialcellfactories.com/content/6/1/30
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omitted from now on, unless otherwise stated. A criterion
was arbitrarily established in order to identify transcripts
that changed significantly, as compared to the reference
strain (JM101). We considered that a gene was signifi-
cantly up-regulated when the transcript level measured by
RT-PCR was ≥ 2 and down-regulated when it was ≤ 0.5.
Genes that showed significant transcriptional changes
were grouped and are described in the following sections.
Glucose transport and phosphorylation
In wild type E. coli cells as JM101, glucose transport and
phosphorylation is mediated by PTS (Figure 1). In con-
trast, PTS mutants (PB12 and PB13) utilize galactose per-
mease (GalP) and glucokinase (Glk) to transport and
phosphorylate glucose, respectively (Figure 2) [2,17]. In
addition to these genes, we analyzed transcriptional
responses of some genes encoding carbohydrate trans-
porters to PTS inactivation or to plasmid presence. The
ptsG transcript levels were 2.5- and 4-fold up-regulated in
PB12 and PB12-ev2, respectively (additional file 1). The
ptsG gene is regulated in a very complex manner by several
proteins including ArcA/ArcB system, cAMP-CRP com-
plex, Mlc, FruR and Fis [26-28]. In PB12, the up-regula-
tion of some genes regulated by the ArcA/ArcB system may
be explained by the arcB- mutation found in this strain.
PB12 exhibits the same toluidine blue sensitive growth
phenotype as strains lacking ArcA or ArcB activities. There-
fore, it can be assumed that the specific mutation in arcB
selected in strain PB12 is causing ArcA to remain in a non-
phosphorylated state [25]. The galP gene was found to be
strongly up-regulated only in the PTS-Glc+mutants: PB12
(30.5-fold), PB13 (12.7-fold), PB12-ev2 (11.9-fold),
PB13-ev2 (25.4-fold) (additional file 1, Figures 3, 4). This
high induction of galP correlates well with its role in PTS-
strains is also supported by the direct evidence on galP
deletion in PB12 and PB13, which impairs the cell growth
on glucose [17,18]. galP  transcription is controlled by
CRP-cAMP, GalR and GalS [29]. It is assumed that galP
transcription is induced in PTS mutants because they are
capable of synthesizing galactose as autoinducer of the gal
regulon [18]. In turn, galactose inactivates GalR and GalS
repressors of the gal regulon [29]. In order to explore the
possibility that some other genes, encoding carbohydrate
transporters that are capable of internalizing glucose,
could be induced in response to PTS deletion, transcripts
of mglB and malE genes were measured. The mglB tran-
script level, encoding another galactose transporter, was
strongly increased in PB12 (58.9-fold), PB13 (6.7-fold),
JM101-ev2 (2.5-fold), PB12-ev2 (119.9-fold) and PB13-
ev2 (68.8-fold) (additional file 1). These results suggest
that the product of this gene could have a role in glucose
transport in the PTS-  strains. The malKFGE  operon
encodes a maltose transporter system, where the maltose
binding-protein is the product of the malE gene. The tran-
script levels of malE were up-regulated in PB12-ev2 (25.2-
fold) and PB13-ev2 (14.4-fold). All these genes were also
up-regulated in PB12 when growing on glucose as the
only carbon source [18].
Earlier studies have demonstrated that glucose permeabil-
ity of the outer membrane in E. coli is determined by the
major outer membrane porins OmpF, OmpC and LamB
[16]. MTA showed no significant changes of lamB tran-
scription in PB12 or PB13 mutants, in contrast with PTS
mutants transformed with plasmids where it was highly
induced in PB12-ev2 (34-fold) and PB13-ev2 (14-fold).
No changes were detected in the transcript levels of ompF
among all the strains (additional file 1). As can be
observed, the transcription of mlgB and galP genes was
highly induced in a PTS background, while lamB and malE
transcription was strongly up-regulated by both PTS inac-
tivation and presence of the plasmids. The mechanisms
underling these up-regulations remain unknown. How-
ever, mglB and galP genes have in common similar regula-
tory proteins: cAMP-CRP complex, GalS and GalR
(additional file 1). Accordingly, the regulatory mecha-
nism involved in up-regulation of mglB may be a conse-
quence of the GalS and GalR inactivation by endogenous
galactose synthesis. It can be observed that gene expres-
sion patterns of lamB bear resemblance to those of malE
gene. In addition, these genes share some regulatory pro-
teins such as CRP and MalT. Hence it is possible to specu-
late that the regulatory mechanism of lamB  and  malE
inductions in PB12-ev2 and PB12-ev2 may be mediated
by cAMP-CRP complex and/or MalT.
Glycolysis, gluconeogenesis and anaplerotic pathways
Figures 3 and 4 show the most relevant transcriptional
changes for genes from glycolysis (EMP), pentoses phos-
phate (PPP), Entner-Doudoroff pathways and TCA cycle.
These figures show relative transcript levels in strains
PB12, PB13, JM101-ev2, PB12-ev2 and PB13-ev2. The
gene encoding glucokinase (glk) was slightly up-regulated
only in PB12 (2.1-fold) and PB12-ev2 (2.4-fold) (addi-
tional file 1, Figures 3, 4). In wild type E. coli strains, the
glucose transporter of PTS (EIIBCGlc component) couples
the translocation with the phosphorylation of glucose.
PTS is the usual route for the internalization and glucose
phosphorylation, while glucokinase (Glk) plays a minor
role in glycolysis. However, when PTS is inactivated, Glk
acquires great significance, because inactivation of glk in a
PTS-  background causes inability to grow on glucose
[30,31].  glk  transcription is controlled by the fructose
repressor FruR, also known as Cra (Catabolite repressor/
activator) [32,33]. In addition, glk induction in response
to stress caused by the overexpression of foreign proteins
[34] and also in response to PTS deletion (PB12 mutant)
has been reported [18].Microbial Cell Factories 2007, 6:30 http://www.microbialcellfactories.com/content/6/1/30
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Relative transcript levels for genes from carbon central metabolism for PB12 (first value) and PB13 (second value), as com- pared to JM101 Figure 3
Relative transcript levels for genes from carbon central metabolism for PB12 (first value) and PB13 (second 
value), as compared to JM101. Metabolic network showing the relative gene transcription levels of genes related to the 
carbon central metabolism, fermentative pathways and the connection with the common aromatic amino acid pathway. Most 
relevant transcriptional responses in host strains without plasmids are shown: PB12 (first value), PB13 (second value) as com-
pared to JM101. According to the significance criterion, only those relative gene transcription values ≥ 2 (up-regulation, data in 
red) or ≤ 0.5 (down-regulation, data in blue), as compared to JM101 reference strain, are shown. The relative gene transcrip-
tion value for JM101 is always equal to 1 and for that reason was omitted. No significant values were written in black. Metabo-
lites abbreviations: GLC, glucose; G6P, glucose-6-phosphate; F6P, fructose-6-phosphate; PBP, fructose-1,6-biphosphate; DHAP, 
dihydroxyacetone phosphate; GAP, glyceraldehyde 3-phosphate; 1,3-BGP, 1,3-biphosphoglycerate; 3PG, 3-phosphoglycerate; 
2PG, 2-phophoglycerate; PEP, phosphoenolpyruvate; PYR, pyruvate; 6PGLN, 6-phosphoglucono-δ-lactone; 6PGNT, 6-pho-
phogluconate; Ru5P, ribulose-5-phosphate; R5P, ribose-5-phosphate; Xu5P, xylulose-5-phosphate; S7P, sedoheptulose-7-phos-
phate; E4P, erythrose-4-phosphate; Ac-CoA, acetyl coenzyme A; Ac-P, acetyl phosphate; Ac-AMP, acetyl-AMP; CIT, citrate; 
ICT, isocitrate; GOX, glyoxylate; α-KG, α-ketoglutarate; SUC-CoA, succinyl-coenzyme A, SUC, succinate; FUM, fumarate; 
MAL, malate; OXA, oxaloacetate.
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Relative transcript levels for genes from carbon central metabolism for L-Phe overproducing strains Figure 4
Relative transcript levels for genes from carbon central metabolism for L-Phe overproducing strains. Metabolic 
network showing the relative gene transcription levels of genes related to the carbon central metabolism, fermentative path-
ways and the connection with the common aromatic amino acid pathway. Most relevant transcriptional responses in L-Phe 
overproducing strains are shown: JM101-ev2 (first value), PB12-ev2 (second value) and PB13-ev3 (third value), as compared to 
JM101. Metabolites abbreviations are depicted in Figure 3 legend.
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The next glycolytic step is catalyzed by phosphoglucose
isomerase (Pgi). Transcription of the pgi  gene was
increased in the PTS-Glc+ background: PB12 (2.7-fold),
PB13 (2.3-fold), PB12-ev2 (3.1-fold), PB13-ev2 (2.9-
fold). Despite the significance of Pgi in glycolysis, scarce
information is available about the regulation of the pgi
gene.
Phosphofructokinase (Pfk) plays a central role in the con-
trol of the glycolytic flux because it catalyzes one of the
pathway's rate-determining reactions. In E. coli, two dis-
tinct enzymes perform this reaction, Pfk-1 (pfkA) and Pfk-
2 (pfkB), contributing with 90% and 10% of the total
activity, respectively [31]. Therefore, Pfk-1 is the major
phosphofructokinase activity in E. coli. Figures 3 and 4
show that pfkA transcription was slightly down-regulated
in PB13 and PB13-ev2, while, the pfkB gene was induced
in JM101-ev2 (2.9-fold) and PB12-ev2 (4-fold). It is
known that the Cra and CsrA/csrB systems are involved in
the regulation of the pfkA gene [32], but no information is
available about pfkB regulation.
In general, only slight changes were detected in the tran-
scription level of genes related to glycolysis among the
strains. For instance, the gapA transcript, encoding G3P
dehydrogenase, was only increased in PB12-ev2 (2.7-
fold). In addition, gpmA  transcript, encoding phos-
phoglycerate mutase 1, was significantly increased in
PB12 (4.5-fold), PB12-ev2 (6.2-fold) and PB13-ev2 (4.9-
fold), while gpmB was only induced in PB12-ev2 (2.8-
fold) (additional file 1, Figures 3 and 4). Several glycolytic
genes, showed no significant changes in the transcription
profiles among all strains. On the other hand, some of
these genes showed down-regulation responses, for exam-
ple in PB12 only the transcript levels of eno were down-
regulated while in PB13, the transcripts of pfkA, fbaA and
pykA showed significant repression. The presence of plas-
mids caused down-regulation of fbaA, tpiA, gapC-1, gapC-
2 and pykA transcript levels in JM101-ev2, while in PB12-
ev2 were only down-regulated the transcripts of gapC-1
and gapC-2. In PB13-ev2, pfkA, gapC-1, gapC-2, eno y pykA
transcript levels were also down-regulated.
Glycolysis and gluconeogenic pathways share seven of ten
enzymatic reactions, which are reversible reactions. Both
pathways differ in three reactions that permit that both
directions be thermodynamically favourable under differ-
ent physiological conditions. In E. coli, one of these dis-
tinct bypasses in the gluconeogenic pathway is performed
by the fructose-1, 6-biphosphatase enzyme (fbp), which
catalyzes the opposite reaction to Pfk, converting fructose
1,6-biphosphate to fructose 6-phosphate when cells are
growing in gluconeogenic substrates. Transcription of fbp
was moderately up-regulated in PB12 (2.2-fold), as well as
in JM101-ev2 (2.2-fold), PB12-ev2 (5.1-fold) and PB13-
ev3 (3.8-fold) mutants (additional file 1). Another bypass
reaction in gluconeogenesis is the conversion of pyruvate
to PEP. This opposite reaction to pyruvate kinase activity
is carried out by the PEP synthetase (Pps) (Figures 3, 4).
The relative transcription level of ppsA was significantly
up-regulated in response to PTS inactivation and/or plas-
midic presence, as can be observed in PB12 (4.4-fold),
PB13 (2.5-fold), JM101 (5.5-fold), PB12-ev2 (6.5-fold)
and PB13-ev2 (7.0-fold). In addition, some other gluco-
neogenic genes such as pckA (PEP carboxykinase) showed
up-regulation in PB12 (3.4-fold), PB13 (2.9-fold) and
PB12-ev2 (4.9-fold). Likewise, the transcription of genes
encoding malic enzymes, maeB and sfcA were only up-reg-
ulated in PB12 and PB12-ev2 as compared to JM101,
while the sfcA was 2-fold up-regulated in PB12 and 4-fold
in PB12-ev2. Noticeably, gluconeogenic genes such as fbp,
ppsA, pckA, maeB and sfcA exhibited a clear transcriptional
response toward up-regulation in PB12 and PB12-ev2. It
is known that crsA/csrB system regulates fbp and ppsA [35-
37], while Cra regulates ppsA and pckA [32,33], but no
information is available about maeB or sfcA genes.
Dissimilation of pyruvate to organic acids
Pyruvate formate-lyase (PFL) encoded by pflB, is a key
enzyme in the oxidation of pyruvate to acetyl-CoA and
formate when E. coli is growing in anaerobic conditions
[38]. In the present study, E. coli cells were grown expo-
nentially in aerobic conditions and utilized for the Meta-
bolic Expression Analysis. The transcript levels of pflB
were down-regulated in all PTS mutants (with or without
plasmids). Pyruvate dehydrogenase (Ldh) complex,
encoded by the aceEF-lpdA operon, oxidizes pyruvate to
acetyl-CoA and CO2. MTA showed that transcript levels of
the aceEF  were significantly up-regulated in JM101-ev2
and PB12-ev2 (additional file 1, Figures 3, 4). By contrast,
the mRNA levels of the pta-ackA operon, encoding the
enzymes phosphotranscetylase and acetate kinase, respec-
tively, showed down-regulation in PB12 and PB13, but in
PB12-ev2 and PB13-ev2 only the transcripts of ackA were
significantly down-regulated. In addition, the transcrip-
tion of poxB  gene showed up-regulation in PB12 (3.5-
fold), PB12-ev2 (2.3-fold) and PB13-ev2 (2.3-fold) (addi-
tional file 1, Figures 3, 4).
The  acs  gene encodes an acetyl-CoA synthase (Acs), a
high-affinity acetate-scavenging enzyme, which permits E.
coli to survive during starvation periods, utilizing acetate
as a source of energy and building blocks. Thus, acetate
can be further metabolized to produce acetyl-CoA during
periods of nutrient depletion. MTA showed a moderated
up-regulation of the transcription of the acs-actP operon
in PB12 (~6-fold) and JM101-ev2 (~3-fold), whereas this
operon was highly induced in PB12-ev2 (acs: 111-fold,
actP: 55-fold) and PB13-ev2 (acs: 96-fold, actP: 90-fold). It
is known that PTS mutants produce substantially lowerMicrobial Cell Factories 2007, 6:30 http://www.microbialcellfactories.com/content/6/1/30
Page 10 of 20
(page number not for citation purposes)
amounts of acetate as compared to wild type strains [39].
In a previous report, it was shown that PB12-ev2 and
PB13-ev2 mutants in physiological conditions of resting
cells, accumulate 57 and 42% less acetate than JM101,
respectively (table 1)[15]. In addition, it was recently
demonstrated that glucose catabolic repression in PTS
mutants growing on glucose and acetate has been abol-
ished, leading to the simultaneous consumption of both
carbon sources [18,25,40]. All this information is consist-
ent with the current MFA, showing a good correlation
between the down-regulation of genes involved in the
production of acetate (pta-ackA operon), the up-regula-
tion of genes related to acetate consumption and trans-
port (acs-actP operon) and lower acetate accumulation in
PTS mutants. On the other hand, the up-regulation of acs-
actP operon and down-regulation of pta-ackA operon may
be transcriptional responses to the alteration of PEP or
pyruvate pools caused by the PTS inactivation and/or redi-
rection of carbon flux from central metabolism to the
SHIK pathway. These results might indicate that the cell
senses nutritional stress conditions and trigger transcrip-
tional responses to increases the gluconeogenic capacity,
incorporating alternative carbon sources such as acetate or
inducing genes related to carbohydrate transport. A simi-
lar transcriptional response to nutrimental stress has been
previously observed in PB11 mutant grown in minimal
media supplemented with glucose [18,25].
Tricarboxylic Acid Cycle (TCA) and Glyoxylate Bypass
The transcription of gltA, encoding the citrate synthase,
was up-regulated in strain PB12 (5-fold) and in strains
harbouring plasmids: JM101-ev2 (2.3-fold), PB12-ev2
(8.8-fold), and PB13-ev2 (6.8-fold). A similar trend was
observed for the same strains with regard to acnA tran-
scription levels, encoding aconitase isoenzyme, showing
up-regulation in PB12 (6-fold), and JM101-ev2 (3.8-
fold), PB12-ev2 (22.6-fold) and PB13-ev2 (15.3-fold).
The transcripts levels of acnB (aconitase B) and icdA (iso-
citrate dehydrogenase) were only up-regulated in the pres-
ence of the plasmids in JM101-ev2 (3.6-fold), PB12-ev2
(12.7-fold) and PB13-ev2 (9.4-fold), but they did not
change in PB12, whereas, in contrast, they were slightly
down-regulated in PB13 (0.3–0.4 fold). On the other
hand, consistently with its operon organization, the tran-
scription of the sucABCD, encoding 2-oxoglutate dehydro-
genase and succinyl-CoA synthase, wasup-regulated in
PB12 (2.6- to 4.6-fold) and JM101-ev2 (2.7–4.6 fold) but
not in PB13, while it was further induced by the presence
of plasmids in PB12-ev2 (18- to 43-fold) and in PB13-ev2
(9- to 14-fold) (additional file 1). A stronger induction of
the  sdhCDAB  operon transcription, encoding succinate
dehydrogenase, was detected in PB12 (10- to 30-fold),
PB13 (2- to 4-fold) and JM101-ev2 (12- to 16-fold),
which was strongly increased in PB12-ev2 (66- to 170-
fold), PB13-ev2 (39- to 74-fold). Some genes such as fumA
and fumB, encoding two fumarase isoenzymes, were dif-
ferentially regulated among strains. Thus, fumA transcrip-
tion was up-regulated in PB12 (12.4-fold), JM101-ev2 (4-
fold), PB13-ev2 (5.4-fold) and strongly induced in PB12-
ev2 (25.9-fold). On the contrary, fumB transcription was
down-regulated in all strains. The transcription of mdh
showed a pattern similar to acnB and icdA, which was up-
regulated in the presence of the plasmids in JM101-ev2
(3.5-fold), PB12-ev2 (16.7-fold) and PB13-ev2 (6.7-fold),
but it did not change in PB12, whereas it was slightly
down-regulated in PB13 (additional file 1). With regard to
the glyoxylate shunt pathway, the transcription of aceBA
operon, encoding malate synthase A and isocitrate lyase,
respectively, was strongly up-regulated only in PB12-ev2
(aceA: 30-fold, aceB: 50-fold) and PB13-ev2 (aceA: 30-
fold, aceB: 47-fold). Alternatively, the transcripts of glcB
(malate synthase G) were measured, showing up-regula-
tion in PB12 (3.9-fold), PB12-ev2 (5.9-fold) and PB13-
ev2 (3-fold).
Analyzing the current results, it is evident that transcrip-
tional profiles in most of TCA and glyoxylate genes show
a general trend toward up-regulation in PB12, JM101-ev2,
PB12-ev2 and PB13-ev2 (additional file 1). In contrast,
PB13 mutant only showed up-regulation of the sdhCDAB
operon, while the rest of TCA genes remained without sig-
nificant changes. It is important to emphasize that a muta-
tion in arcB gene of PB12 strain has been detected, which
consists in a substitution of Tyr by Cys residue at position
71 and this mutation is not present in PB13. It can be
assumed that t6he arcB mutation is responsible for the
slight up-regulation of most of TCA cycle genes in PB12
strain when growing on glucose as the sole carbon source
[18]. Possibly, it may also explain the differences in the
transcription patterns of most of the TCA cycle genes
observed between PB12 and PB13 strains. However, the
presence of plasmids in JM101-ev2, PB12-ev2 and PB13-
ev2 introduces an additional factor, which up-regulated
most of TCA cycle genes in all these strains by a mecha-
nism still unknown. It should be noted that transcript lev-
els of TCA cycle genes is higher in PB12-ev2 than in
JM101-ev2 and PB13-ev2.
Genes encoding regulatory proteins of carbon central 
metabolism
With the purpose of finding some correlations between
transcriptional changes of metabolic genes with variations
in the transcript levels of genes coding regulatory proteins
of metabolic genes, we measured transcript levels of some
regulatory proteins such as Cra, RpoD, RpoS, FNR, CsrA/
crsB and ArcA/ArcB systems [32-51]. Despite transcript
levels of some regulatory genes such as rpoS, csrB, rpoD,
arcA and fnr were significantly regulated in some strains
(additional file 1), however, no clear correlation was
found between gene expression patterns of regulatoryMicrobial Cell Factories 2007, 6:30 http://www.microbialcellfactories.com/content/6/1/30
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genes with those of the genes regulated by them. In order
to establish correlations in these gene expression patterns,
it would be necessary to know the phosphorylation state
of the regulatory protein or the presence/concentration of
specific cofactors that alter their activity.
Pentoses phosphate and Entner-Doudoroff pathway
The zwf gene encodes G6P dehydrogenase (G6PDH) and
its regulation is growth-rate dependent [52]. Like poxB
gene, zwf is activated by SoxS in response to oxidative
stress [53] and by the regulator of multiple resistance anti-
biotics, Mar [54]. The G6PDH activity plays an important
role in controlling carbon distribution at the G6P node,
because it directs carbon flux through the oxidative
branch of the pentose phosphate pathway (PPP) depend-
ing on NADP+ availability. MTA showed that relative tran-
scription of zwf was down-regulated in PB13-ev2, while
the transcription of gnd gene, encoding the phosphoglu-
conate dehydrogenase was down-regulated in PB12 and
PB13 (figure 3). Isomerization and epimerization reac-
tions of ribulose-5-P interconnect the oxidative and non-
oxidative branches of PPP and are coded by rpe and rpiA
genes, respectively. The transcription of rpe  gene was
down-regulated only in PB13, while the rpiA transcription
was slightly up-regulated in PB12-ev2 (2.7-fold) and
PB13-ev2 (2.2-fold). Enzymes constituting the non-oxida-
tive branch of PPP, such as transketolases and transaldo-
lases activities interconnect glycolysis with the oxidative
branch of PPP. In E. coli, each of these activities is cata-
lyzed by two isoenzymes, encoded by tktA, tktB and talA,
talB for transketolase and transaldolase activities, respec-
tively. Transketolase A (tktA) is the major isoenzyme and
accounts for about 70–80% of transketolase activity
[55,56]. As expected, the overexpression of tktA gene from
the plasmid pCLtkt strongly increased the transcripts lev-
els of tktA in JM101-ev2 (65.8-fold), PB12-ev2 (162.6-
fold) and PB13-ev2 (75.1-fold), as compared to chromo-
somal tktA transcription in JM101. It is worth to empha-
size the difference in the levels of tktA  transcription
among these strains, which varied depending on the
genetic background, reaching its maximum value in PB12-
ev2. The regulatory mechanism implicated in the varia-
tion of tktA transcript levels is unknown. This transcrip-
tional variability can be of significance and should be
taken into account, especially when engineering distinct
mutants by using multicopy plasmids. In the context of
aromatic amino acid production, the transketolase over-
expression improves significantly the yield of aromatic
compounds, presumably by increasing the availability of
E4P [6]. Therefore, the different transcript levels of tktA
detected among the strains may affect the yield and pro-
ductivity of L-Phe. The tktA gene, either the chromosomal
or plasmid copy, is under the control of its own regulatory
region.
Transcription of the talA-tktB  operon exhibited similar
patterns, which is consistent with their transcriptional
organization. Thus, the relative gene transcription of talA
was up-regulated in PB12, PB12-ev2 and PB13-ev2 by 5.7-
, 3.8- and 2.8-fold, respectively, while the transcripts of
tktB were also induced in PB12, PB12-ev2, PB13-ev2 by
2.9-, 2.7- and 2.2-fold, respectively. It has been demon-
strated that overexpression of either transketolase or
transaldolase has a positive effect on the synthesis of aro-
matic compounds. For this reason, the significant induc-
tion of talA-tktB operon in PB12-ev2 PB13-ev2 results of
particular interest for L-Phe production. It is known that
the CreBC two-component system positively regulates the
transcription of the talA-tktB operon in E. coli cells grow-
ing in minimal media [57], but it is not known which is
the signal or the regulatory mechanism responsible of this
induction.
The edd-eda operon encodes enzymes of the Entner-Dou-
doroff pathway (EDP)[58]. No significant changes were
observed in the transcription levels of edd and eda genes
among all strains (additional file 1).
Common and specific pathways of aromatic amino acids
The common aromatic amino acid pathway, so-called
shikimate (SHIK) pathway, encompasses seven serial
enzymatic reactions. The first reaction is catalyzed by the
enzyme DAHP synthase, which condensates E4P and PEP
to yield DAHP. E. coli has three DAHP synthases isoen-
zymes encoded by aroF, aroG and aroH genes, which are
transcriptionally regulated by either transcriptional
repressors (TyrR or TrpR) or attenuation mechanisms
(additional file 1). As expected, the transcript levels of
aroGfbr, expressed from the plasmid pJLBaroGfbr under the
control of lacUV5 promoter, were higher in JM101-ev2
(4.4-fold), PB12-ev2 (10.6-fold) and PB13-ev2 (10-fold)
with regard to the chromosomal level of wild type aroG in
JM101. However, as can be observed, these levels were sig-
nificantly different between PTS+ and PTS-Glc+ strains for
unknown reasons. It is important to note that 10-fold
increase in aroGfbr  transcript levels were apparently
enough to overproduce L-Phe at high yields and produc-
tivities in PB12-ev2 (table 1). Alternatively, transcript lev-
els of aroF and aroH were slightly up-regulated (~2-fold)
in JM101-ev2 and PB13-ev2, respectively. Transcription
control of aroF is mediated by the TyrR repressor, whereas
aroH transcription is repressed by TrpR [59]. Transcrip-
tional analysis showed a slight increase of the tyrR mRNAs
only in PB12 and PB12-ev2, while up-regulation of trpR
transcripts were also detected in all strains harbouring
plasmids with regard to JM101 (additional file 1). It is
known that the repression exerted by TyrR or TrpR is
cofactor-dependent (tyrosine or tryptophan)[59]. No
apparent correlation was found between the up-regula-Microbial Cell Factories 2007, 6:30 http://www.microbialcellfactories.com/content/6/1/30
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tion of these repressors and the transcripts levels regulated
by them, such as aroF or aroH.
Some genes known to be involved in the synthesis of aro-
matic amino acids showed a decrease of transcript levels
in PB12 and PB13, such as aroD (3-dehydroquinate dehy-
dratase) and aroA (5-enol-pyruvyl-shikimate 3-phosphate
synthase) (additional file 1). MTA revealed that the best L-
Phe producing strains (JM101-ev2 and PB12-ev2) showed
no down-regulation of genes involved in shikimate path-
way (additional file 1); while transcript levels of aroB (3-
dehydroquinate synthase) were slightly down-regulated
(2-fold) in PB13 and PB13-ev2 strains. On the contrary,
JM101-ev2 and PB12-ev2 strains showed up-regulation of
transcript levels of aroC (chorismate synthase) (2–3 fold).
Down-regulation of genes may be related to a decreased in
enzyme pools and thereby with enzymatic limitation
within a pathway. In addition, L-Phe overproducing
PB13-ev2 strain also showed down-regulation of the tran-
script levels of aroE  (shikimate dehydrogenase) (addi-
tional file 1). Therefore, the down-regulation of aroB, aroE
y  aroA  in PB13-ev2 may be associated with the lower
yields and specific productivity of L-Phe synthesized from
glucose, as compared to either JM101-ev2 or PB12-ev2
(additional file 1). It is important to note that enzymatic
levels of shikimate dehydrogenases (aroE, ydiB) and shiki-
mate kinases (aroK and aroL) are rate-limiting steps in all
L-Phe overproducing strains, as can be inferred by the
accumulation of DHS and SHIK (table 1).
Tryptophan, tyrosine and phenylalanine biosynthetic 
pathways
The specific biosynthetic pathways of aromatic amino
acids are also strongly controlled at the transcriptional
and enzymatic level [59]. The biosynthetic pathway of
tryptophan (L-Trp) starts with the conversion of CHO to
antranilate, catalyzed by the antranilate synthase (coded
by trpE) and ends with the synthesis of tryptophan. The
last step is catalyzed by tryptophan synthase (coded by
trpAB). The transcript levels of the trpE and trpA genes
belonging to the trpLEDCBA  operon were measured,
showing down-regulation of these genes in all strains,
compared to JM101 (additional file 1). E. coli utilizes two
distinct mechanisms for regulating transcription of the
trpLEDCBA operon: repression/activation and attenuation
[59,60]. Repression of this operon is mediated by TrpR
protein. The TrpR regulation mechanism is cofactor-
dependent. Likewise, the attenuation of trp  operon
depends on charged tRNATrp [60,61]. As previously men-
tioned, the transcript levels of trpR  were up-regulated
about 2–3 fold in strains carrying out plasmids. A positive
correlation can be observed between the increase of the
transcript levels of repressor trpR and the repression of the
trpLEDCBA operon. However, the presence of tryptophan
as cofactor must be considered in this regulation mecha-
nism.
The committed step toward the biosynthesis of tyrosine is
catalyzed by the bifunctional enzyme chorismate mutase-
prephenate dehydrogenase, coded by tyrA gene (Figure 5).
The mRNA levels of tyrA showed a slight up-regulation
only in PB12-ev2. The transcription pattern of tyrA is sim-
ilar to that of aroF gene (additional file 1), which is con-
sistent with the organization of these genes in the aroF-
tyrA operon that controlled by TyrR [59,62,63].
In E. coli, CHO is converted into prephenate (PPA) by the
enzyme chorismate mutase (CM). PPA is then further
metabolized by the enzyme prephenate dehydratase
(PDT) into phenylpyruvate (PPY); both activities are co-
localized in the bifunctional enzyme CM-PDT encoded by
pheA  gene. Both activities of this enzyme are feedback
inhibited by L-Phe. It is worth mentioning that for the
metabolic transcription analysis of chromosomal pheA
(wt) and the truncated version of pheAev2 gene, specific
primers were designed in order to distinguish between the
mRNA coming from either pheA  (wt) or pheAev2  gene
(table 3). The specific primers for the PCR amplification
of the pheA (wt) hybridize in the regulatory domain R,
which is absent in pheAev2 gene. MTA showed that mRNAs
levels of chromosomal pheA gene were slightly increased
only in PB12 (2-fold) but down-regulated in JM101-ev2,
PB12-ev2. It is known that transcription of wt pheA gene
is solely regulated by attenuation at a transcription termi-
nator located upstream from the pheA  structural gene.
According to the established attenuation mechanisms, the
amount of charged tRNAPhe (pheR) regulates the pheA tran-
scription via attenuation control of transcription
[59,64,65]. Therefore, altered regulation of wt pheA gene
may be explained by the mechanism of attenuation. The
overexpression of the pheAev2 transcript from the plasmid
pTrcpheAev2  was clearly evidenced by RT-PCR analysis,
showing a very strong up-regulation in JM101-ev2 (92-
fold), PB12-ev2 (126-fold) and PB13-ev2 (40-fold). The
expression pheAev2 from the multicopy plasmid also seems
to be dependent on the genetic background, having the
highest transcription in PB12-ev2. The pheAev2  gene is
under the control of the trc promoter, which is inducible
by IPTG. Because of the overexpression of pheAev2 from
plasmid pTrcpheAev2 in the strains JM101-ev2, PB12-ev2
and PB13-ev2, it is assumed that this plasmid is the major
source of pheA transcripts.
The last step in the biosynthesis of Phe and Tyr requires
transamination of HPP or PPY, respectively, with gluta-
mate as amino donor. Although, in E. coli there are three
enzymes with transaminase activity encoded by tyrR, aspC
and ilvE genes, it is seems that under normal physiological
conditions Phe and Tyr syntheses are primarily carried outMicrobial Cell Factories 2007, 6:30 http://www.microbialcellfactories.com/content/6/1/30
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Relative transcript levels for genes from the shikimate and aromatic specific pathways Figure 5
Relative transcript levels for genes from the shikimate and aromatic specific pathways. Metabolic transcription 
analysis of genes related to the shikimate pathway and specific aromatic amino acid pathways. Metabolites abbreviations: PEP, 
phosphoenolpyruvate; E4P, erythrose 4-phosphate; DAHP, 3-deoxy-D-arabino-heptulosonate-7-phosphate; DHQ, 5-dehydro-
quinate; DHS, 5-dehydroshikimate; SHIK, shikimate; S3P, shikimate 5-phosphate; ESPS, 3-enolpyruvylshimate-5-phosphate; 
CHO, chorismate; PPA, prephenate; PPY, phenylpyruvate; HPP, 4-hydroxyphenylpyruvate; ANTA, anthranilate; PRAA, N-(5'-
Phosphoribosyl)-anthranilate; CDRP, enol-1-o-carboxyphenylamino-1-deoxy-ribulose phosphate; I3GP, indol-3-glycerol phos-
phate; IND, indole; L-Phe, phenylalanine; L-Tyr, tyrosine; L-Trp, tryptophan, L-Ser, serine; L-Gln, glutamine; L-Glu, glutamate.
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H2O
NADP+
Pi
ADP  
Pi
Pi
E4P
Pi
pentoses Glycolysis 
PEP
PEP 
tyrA   pheAev2
tyrB  
aspC  
ANTA  
PRAA  
CDRP  
I3GP  
L-Trp  
trpE
trpD  
trpC  
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Table 3: Nucleotide sequences of the primers sets used for RT-PCR assays. The rest of the primer sets has been already reported 
[18].
Gene Primer Primer sequence
Aromatic amino acid pathways
aroF aroFa 5' CAGAATCCGTGGTTGCTCAA 3'
aroFb 5' CGGTTGCTCGGAAGACTGAT 3'
aroG aroGa 5' GTCGGCTTCAAAAATGGCAC 3'
aroGb 5' CCCCATTTCGTTACGGACAG 3'
aroH aroHa 5' CTGCTCGATCCACGATCTCA 3'
aroHb 5' AGGTGCGCATTACGATTTCC 3'
aroB aroBa 5' GTTATCCTCCCTGACGGCG 3'
aroBb 5' ACCAGCGTAGTATCGCGACC 3'
aroD aroDa 5' AGCCGAAGAAATCATTGCCC 3'
aroDb 5' ACGTCAGCACATCGCTGGTA 3'
aroE aroEa 5' AATCCGATAGCCCACAGCAA 3'
aroEb 5' TCATTGATGGGTGCCAACAC 3'
ydiB ydiBa 5' AAAAGCGGGATTGCCATTTA 3'
ydiBb 5' CAGTTCCGCGCATTTTGAG 3'
aroL aroLa 5' CCGGAAGAAGATTTACGGCC 3'
aroLb 5' TGCGCAACTTCGCGATATAG 3'
aroK aroKa 5' GCACTATTGGGCGCCAGTTA 3'
aroKb 5' GAAAACCCAGCCCACATCAG 3'
aroM aroMa 5' CCAGAAGCAGGCGAAGACAC 3'
aroMb 5' TCAACCACACCTTGCAGGTC 3'
aroA aroAa 5' CATATTCCTGATGCGGCGAT 3'
aroAb 5' TCGGTCTCTTTAACACGCCAG 3'
aroC aroCa 5' GGGACATCGCGCTATACCAC 3'
aroCb 5' AACAAGCCAATGCTGGTGC 3'
pheA pheARa 5' ATGACCCGTCTGGAATCACG 3'
pheARb 5' GCTTTTTGCATTTCCGCTG 3'
pheA-ev2 pheAa 5' ACTCAGCAGGCTTTGCTCCA 3'
pheAb 5' GCCGCAAGATGGGAATAAGAA 3'
tyrA tyrAa 5' GTCAGATGGGACGCCTGTTC 3'
tyrAb 5' GGCAACAATATCAGCCGCTC 3'
aspC aspCa 5' GGCGATTCGCGCTAACTACT 3'
aspCb 5' GCTCTTGTTCCCAAATCGCA 3'
trpE trpEa 5' CGCAACTGTCAGCGGAAAAT 3'
trpEb 5' GGCCTGAATACGGGTGCTTT 3'
trpA trpAa 5' CGTTCCTTTCGTCACGCTC 3'
trpAb 5' CGTTCCTTTCGTCACGCTC 3'
Aromatic amino acid transport
pheP phePa 5' CGGCTGTATTGCTGGGCTAC 3'
phePb 5' AAATGAACCGGATACCGGCT 3'
aroP aroPa 5' TGGTAATCAACTGGGCGATG 3'
aroPb 5' CGGATAAAGCAGAGCAGGGA 3'
tyrP tyrPa 5' CCGGTGTTGGTTTTAGCGTT 3'
tyrPb 5' CGGAACATGCTGGTACACCTC 3'
mtr mtra 5' TTGATGTGCTGGTACAGGCG 3'
mtrb 5' GAGGAACGAACTCGCTACCG 3'
shiA shiAb 5' ATTATCAAGCTGCCGCGAAA 3'
shiAb 5' CAATTCGCACAGTCGTAGCG 3'
ilvE ilvEa 5' AAGGCATCCGTTGCTACGAC 3'
ilvEb 5' CGGGAAGCGATAGATTTTGG 3'
aroP aroPa 5' TGGTAATCAACTGGGCGATG 3'
aroPb 5' CGGATAAAGCAGAGCAGGGA 3'
RegulatorsMicrobial Cell Factories 2007, 6:30 http://www.microbialcellfactories.com/content/6/1/30
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by the product of tyrB  gene, the aromatic aminotrans-
ferase [59]. However, MTA showed no higher levels for
the tyrB transcripts, while transcript levels of aminotrans-
ferase encoded by ilvE  showed no significant changes
among all strains, and aspC showed down-regulation in
PB12 and PB13.
Aromatic amino acids transport
The aromatic amino acids are imported across the inner
membrane of E. coli by distinct transport systems. The
aroP gene encodes the general aromatic transport system
for all three aromatic amino acids, while pheP, tyrP and
mtr genes encode specific transporters of high-affinity for
L-Phe, L-Tyr and L-Trp, respectively. L-Trp is also trans-
ported by the low-affinity transporter encoded by tnaB, a
member of the tnaAB operon. It is not known whether
these transporters are capable to excrete the aromatic
amino acids as well. MTA detected variations in the tran-
scriptional expression of genes related to aromatic trans-
port, showing that mRNA levels of aroP  (Phe/Tyr/Trp
transporter)pheP  (Phetransporter) and tyrP  (Tyr trans-
porter)were up-regulated in JM101-ev2 (2- to 5-fold).
Similarly, pheP and mtr (Trp transporter) transcript levels
showed up-regulation in PB12-ev2 (2- to 3-fold) (addi-
tional file 1). The transcript levels of the shiA gene (shiki-
mate transporter) were slightly down-regulated in PB12,
JM101-ev2, PB12-ev2, and PB13-ev2 (additional file 1).
Reverse engineering strategies to further improve the L-
Phe biosynthesis
One approach considers the analysis of transcriptional
responses in the best overproducing strains (PB12-ev2),
which could be responsible for the improvement of bio-
synthetic capacities. This analysis can provide the basis for
the implementation of appropriate genetic strategies in
order to modulate the transcription of target genes and
achieve similar transcriptional responses. For instance,
one of the most outstanding transcriptional responses
triggered by PTS inactivation and the presence of plasmids
(PB12-ev2, PB13-ev2) was the up-regulation of the acs-
actP operon. This response suggests that PTS mutants have
increased their capacity to uptake and metabolize acetate,
which is in agreement with lower accumulation of acetate
in these mutants. Therefore, the overexpression of acs-actP
operon may be useful to reincorporate by-products, such
as acetate, into the central metabolism, and then, to chan-
nel them into the desired production pathway. In fact, the
overexpression of Acs in E. coli has been recently assessed,
resulting in a significant decrease of acetate accumulation
and more efficient acetate assimilation [66]. However, the
overexpression of ActP has not been assessed yet. We pro-
pose that simultaneous gene overexpression of these two
genes may have a synergistic effect, increasing the cell
capacity to reincorporate acetate into central metabolism,
and thereby, decreasing the carbon waste as byproducts
and the acetate toxicity in the microbial cultures as well.
MTA showed a differential regulation of some genes that
are exclusively gluconeogenic even between mutants with
the same PTS-Glc+ phenotype. Thus, fbp, ppsA, pckA, maeB,
sfcA and glyoxylate shunt genes showed a coordinated up-
regulation in PB12 and PB12-ev2 strains. Unlike, PB13,
PB13-ev2, and JM101-ev2 strains showed only up-regula-
tion of two gluconeogenic genes (fbp, ppsA or pckA). It has
been reported that the overexpression of the fbp gene sig-
nificantly improved lysine production in C. glutamicum
[67]. This improvement was associated to the increase of
carbon flux through oxidative branch of the PP pathway
and the concomitant increase in the production NADPH,
which is required in the biosynthesis of lysine. In L-Phe
biosynthetic pathway, NADPH is also required; therefore,
it is possible to propose that coordinated expression of
some exclusively gluconeogenic genes may have a positive
trpR trpRa 5' CAGAACAGCGTCACCAGGAG 3'
trpRb 5' TGGCGTCAGCATCAGGTTTA 3'
tyrR tyrRa 5' GGCGAGCTGTCAGCTTTTTG 3'
tyrRb 5' CGCTTTCCAGCCAACGTAAA 3'
csrA csrAa 5' TCTGACTCGTCGAGTTGGTGA 3'
csrAb 5' GGGCATTTACGCCAATACGT 3'
rpoD rpoDa 5' GATTCTGCGACCACCGAAAG 3'
rpoDb 5' TCGATACCGAAACGCATACG 3'
rpoE rpoEa 5' GAACTATTGAGTCCCTCCCGG 3'
rpoEb 5' CGGACAATCCATGATAGCGG 3'
fnr fnra 5' CGGAAAAGCGAATTATACGGC 3'
fnrb 5' TTCGTTGAGTGTGAACGGGA 3'
Carbohydrate transport
malE malEa 5' AGAAATTCCCACAGGTTGCG 3'
malEb 5' TTCAGCCAACAGGCCAGATT 3'
Table 3: Nucleotide sequences of the primers sets used for RT-PCR assays. The rest of the primer sets has been already reported [18]. 
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impact to improve the biosynthesis of aromatic com-
pounds.
Conclusion
• Many genes exhibited opposite transcriptional trends
towards either down- or up-regulation, as a consequence
of the PTS inactivation.
• The presence of multicopy plasmids caused a clear tran-
scriptional trend mainly toward up-regulation of a broad
spectrum of genes, and not toward down-regulation. The
functions of the genes involved in the observed response
suggest an increased demand for energy and/or precursor
molecules synthesis, which in turn, is an indication of
plasmid burden.
• The most outstanding differences in transcriptional
responses of metabolic genes between PB12 and PB13
were found in genes related to TCA cycle and glyoxylate
shunt.
• Transcription levels of a gene expressed from the same
plasmid (as tktA and pheAev2) was found to strongly vary
depending on the genetic background of the host strains.
This factor may affect yields and productivities in engi-
neered strains.
• Only few transcriptional changes were detected in the
shikimate pathway. Two genes, aroD  and  aroA, were
down-regulated in PB12 and PB13 as consequence of PTS
inactivation. In the presence of plasmids, only PB13-ev2
showed down-regulation of aroB, aroE and aroA genes.
Some genes involved in the aromatic amino acid trans-
port were significantly induced in JM101-ev2 (aroP, pheP,
tyrP) and PB12-ev2 (pheP, mtr).
• Noticeably, some exclusive gluconeogenic genes such as
fbp, ppsA, pckA, maeB, sfcA and glyoxylate shunt genes
showed a simultaneous up-regulation in PB12 and PB12-
ev2 strains. Unlike, PB13, PB13-ev2, and JM101-ev2
strains showed only up-regulation of two gluconeogenic
genes (fbp, ppsA or pckA).
• Some genes encoding regulatory proteins of metabolic
genes showed significant changes in transcript level on
some of the different genetic backgrounds studied. How-
ever, because the activity of most regulatory proteins is
dependent on either cofactor binding or phosphorylation
state, and this information was not known, it was not pos-
sible to find a clear correlation between transcriptional
levels of genes encoding regulatory proteins and their cor-
responding regulated genes.
Methods
Strains, plasmids and construction of L-Phe overproducing 
strains
All strains and plasmids used in this study are listed and
described in table I. Escherichia coli JM101 (PTS+) is the
parental strain of PB11, PB12 and PB13 mutants. Details
about the construction of the plasmids pJLBaroGfbr,
pCLtkt, pTrcpheAev2, as well as the generation of the
evolved feedback insensitive chorismate-mutase
prefenate-dehydratase, CM-PDTev2 (pheAev2), have been
described [15]. For the generation of L-Phe overproducing
mutants, JM101, PB12 and PB13 strains were transformed
with three plasmids harbouring genes that encode for a
feedback inhibition resistant DAHP synthase (pJL-
BaroGfbr), transketolase (pCLtkt) and truncated evolved
CM-PDTev2 (pTrcpheAev2)(table I). The L-Phe overproduc-
ing mutants were designated JM101-ev2, PB12-ev2 and
PB13-ev2.
Growth media and culture conditions
All stock cultures were stored at -70°C in Luria-Bertani
medium containing 50% of glycerol. Overnight cultures
were prepared in M9 medium supplemented with 5 g/l of
yeast extract and 10 g/l of glucose. Then, the cells were
subcultured by duplicate in shake flasks containing 50 ml
of the same media mentioned above at 37°C and 250
r.p.m. In the case of transformed strains, appropriate anti-
biotics were added for plasmid maintenance and 100 µM
of IPTG for induction of the aroGfbr and pheAev2 genes. Nei-
ther antibiotics nor IPTG were added for strains without
plasmids. Cells were harvested by centrifugation when
growing in exponential phase (OD600nm= 2) for RNA puri-
fication. The culture procedure to prepare the cells for
transcriptome analyses was exactly the same reported pre-
viously to prepare the resting cells for L-Phe production
cultures [15]. This analogy was chosen to correlate the
transcriptome analysis with the L-Phe production cultures
data.
RNA extraction and cDNA synthesis
Total RNA extraction was performed using hot phenol
equilibrated with water [40]. After extractions, RNA was
precipitated with 3 M sodium acetate/ethanol and centri-
fuged 20,000 g, 15 min., at 4°C. Supernatant was dis-
carded and the RNA suspended in water. RNA was treated
with DNAse kit (DNA-free, Ambion) and its concentra-
tion carefully measured by densitometry in agarose gels
and by 260/280 nm ratio absorbance. cDNA was synthe-
sized using RevertAid H First Strand cDNA Synthesis kit
(Fermentas Inc.) and a mixture of specific DNA primers b
(Table 2). cDNA was used as template for RT-PCR assays.
Reproducibility of this procedure was determined by per-
forming two separate cDNA synthesis experiments from
the RNA extracted for each strain. Similar results wereMicrobial Cell Factories 2007, 6:30 http://www.microbialcellfactories.com/content/6/1/30
Page 17 of 20
(page number not for citation purposes)
obtained for the transcription levels of all these duplicate
experiments.
Real-time PCR
Real-time PCR (RT-PCR) was performed with the ABI
Prism7000 Sequence Detection System (Perkin-Elmer/
Applied Biosystems) using the SYBR Green PCR Master
Mix (Perkin-Elmer/Applied Biosystems). Amplification
conditions were 10 min at 95°C, and a two step cycle at
95°C for 15 s and 60°C for 60 s for a total of 40 cycles.
The primers for specific amplification were designed using
the Primer Express software (PE Applied Biosystems).
Most primers used for gene amplification of glycolysis,
gluconeogenesis, anaplerosis, PPP, TCA, Entner-Doudor-
off, glucose transport have been already reported [18,40].
Table 3 shows the sequences of primers sets used for
amplification of genes related to the metabolism of aro-
matic amino acids (pathways, transport and global regu-
lators). The size of all amplimers was 101 bp. The final
primer mix concentration (a plus b) of a total volume of
15 µl was 0.2 µM. 5 nanograms of target cDNA for each
gene was added to the reaction mixture. All experiments
were performed in triplicate for each gene of each strain,
obtaining very similar values (differences of less than 0.3
SD). A non-template control reaction mixture was
included for each gene. The quantification technique used
to analyze data was the 2-∆∆CT method described by Livak
and Shmittgen [68] and the results were plotted. The data
were normalized using the ihfB gene as an internal control
(housekeeping gene). We detected the same transcription
level of this gene in all the strains in the conditions in
which the bacteria were grown. JM101 was used as refer-
ence strain for all strains, either strains with or without
plasmids. The transcript levels of PB12, PB13, PB12-ev2
and PB13-ev2 were normalized subtracting first the
housekeeping gene value, and then subtracting the corre-
sponding transcript value of reference strain (JM101) of
the same gene. Thus, all the transcripts levels of JM101
were arbitrarily adjusted to one. Therefore, the gene tran-
scription data plotted in all Figures are expressed as rela-
tive transcription to JM101 strain. It is important to
comment that relative gene transcription in table 3 only
allows the comparison of transcript levels of the same
gene among all strains, but not among distinct genes.
Results of relative transcription showed in additional file
1 and Figures 2, 3, 4, 5, 6 are the averages of six measure-
ments of the RT-PCR transcription values for each gene.
Half of the values were obtained from two different
cDNAs generated in independent experiments. The RT-
PCR transcription values obtained for each gene differ less
than 30%.
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Table 2: E. coli strains and plasmids used for the construction of L-phenylalanine overproducing strains in this study.
Strains Relevant features Reference number
JM101 supE, thi, ∆(lac-proAB), F' 70
PB11 Derived from JM101, but ∆ptsHI-crr; impaired growth on glucose as sole carbon source. 2
PB12 Derived from PB11; PB12 grows faster than PB11 on glucose 2
PB13 Derived from PB11; PB13 grows faster than PB11 on glucose. 2
Plasmids
pCLtkt tktA (comes from replicon pCL1920, resistant to streptomycin or spectinomycin. 6
pJLBaroGfbr aroGfbr under the control of lacUV5 promoter, lacIq and tet genes. Replication origin from 
pACYC184.
15
pTrcpheAev2 Evolved feedback insensitive pheAev2 under the control of lacUV5 promoter. Ev2 superscript 
means 2nd version of evolved pheAfbr gene.
15
Engineered strains
JM101-ev2 JM101 transformed with pJLBaroGfbr, pCLtkt and pTrcpheAev2 15
PB12-ev2 PB12 transformed with pJLBaroGfbr, pCLtkt and pTrcpheAev2 15
PB13-ev2 PB13 transformed with pJLBaroGfbr, pCLtkt and pTrcpheAev2 69Microbial Cell Factories 2007, 6:30 http://www.microbialcellfactories.com/content/6/1/30
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